Impact of Stress Hyperglycemia Ratio on Adverse Outcomes in Patients With Chronic Thromboembolic Pulmonary Hypertension
Open Access
- 2 December 2025
- journal article
- Published by Wiley in Clinical and Translational Science
- Vol. 18 (12) , e70426
Abstract
Prognostic assessment of chronic thromboembolic pulmonary hypertension (CTEPH) remains challenging. Stress hyperglycemia, a condition where glucose metabolism is regulated during stress, has been regarded as an indicator of acute hyperglycemia. The stress hyperglycemia ratio (SHR) serves as a more precise marker for this state. This research intended to investigate the prognostic function of SHR in CTEPH, as its link to poor outcomes is uncertain. Clinical deterioration events were the primary endpoint. LASSO regression was utilized for variable selection and dimensionality reduction to identify key features and mitigate overfitting. Kaplan–Meier analysis, multivariable Cox regression, and restricted cubic splines were primarily used to investigate the link between SHR and adverse clinical outcomes. Internal validation was performed using bootstrap resampling. Sensitivity analysis was performed to assess the robustness of the findings. The study included a sum of 451 patients with CTEPH; over a median follow‐up of 21 months, 89 (19.7%) patients encountered adverse outcomes. Kaplan–Meier analysis indicated that patients having elevated SHR levels exhibited a markedly higher overall incidence of adverse events. Restricted cubic spline analysis showed a linear relationship between SHR and adverse events. Multivariable Cox regression analysis indicated that higher SHR independently predicts adverse outcomes, whether treated as continuous (hazard ratio, 1.541; 95% confidence interval, 1.252–1.896, p < 0.001) or categorical (hazard ratio, 2.419; 95% confidence interval, 1.268–4.616, p = 0.007). Internal validation demonstrated that the original C‐index was 0.693, with a bias‐corrected C‐index of 0.675 after bootstrap validation. In patients with CTEPH, higher SHR is independently associated with clinical worsening. The prognostic significance of SHR remained robust across internal validation and multiple sensitivity analyses.Keywords
This publication has 39 references indexed in Scilit:
- 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary HypertensionRevista Española de Cardiología (English Edition), 2016
- Relative Hyperglycemia, a Marker of Critical Illness: Introducing the Stress Hyperglycemia RatioThe Journal of Clinical Endocrinology & Metabolism, 2015
- Impact of Diabetes in Patients with Pulmonary HypertensionPulmonary Circulation, 2015
- Stress hyperglycemia: an essential survival response!Critical Care, 2013
- Oxidative stress in the etiology of age-associated decline in glucose metabolismLongevity & Healthspan, 2012
- Stress hyperglycaemiaThe Lancet, 2009
- Diagnostic et prise en charge de l’hypertension pulmonaire postembolique : le rôle du pneumologueRevue de Pneumologie Clinique, 2008
- Stress: A risk factor for serious illnessMetabolism, 2002
- Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the ratActa Diabetologica, 2001
- Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in cultureDiabetologia, 1996